The Principles behind Targeted Therapy for Cancer Treatment

Abstract

The advent of molecular and genetic advancement in the field of oncology research has led to a shift in the treatment of various forms of cancer from traditional chemotherapeutics to targeted therapy. The principle behind targeted therapy is utilizing therapeutics designed to interfere with specific molecules that have a relatively specific or higher expression profile in cancer cells and are critical for cancer growth and progression. These were designed as mechanistic therapeutics in the form of small molecules and monoclonal antibodies. Currently, they have been modified to incorporate passive or active targeting delivery systems to improve their specific distribution and enhance cytotoxicity towards cancer cells while simultaneously reducing their systemic toxicity profile. Passive targeting employs encapsulated delivery systems to take advantage of the enhanced permeation and retention effect of the tumor microenvironment, while active targeting relies on receptor mediated interactions, such as cell surface ligands conjugated to the therapeutic moiety. A synergistic strategy for cancer therapy is evolving, where precision medicine acts as a diagnostic prerequisite for targeted therapy via prognostic biomarkers and tumor genotyping. Despite the plethora of research undertaken in targeted therapy, limited numbers were approved for clinical use, and significant challenges remain to be addressed.

Unveiling the potential of Muscadine grape Skin extract as an innovative therapeutic intervention in cancer treatment

“…This combined approach shows promise for improving the effectiveness of hormone therapy interventions. Targeted therapies prevent cancer cell growth and spread by inhibiting specific molecules ( Wabel & Khajah, 2019 ). MGSE’s capacity to regulate signaling pathways renders it a prospective candidate for integration with targeted therapeutic approaches.…”

Melanin and Melanin-Functionalized Nanoparticles as Promising Tools in Cancer Research—A Review

“…Targeted cancer therapy (TCT) is an advanced treatment method utilizing therapeutic agents designed to interfere with specific molecular targets expressed within cancer cells (e.g., signaling molecules, growth factors, apoptosis modulators, and cell-cycle proteins) in order to restrain tumor growth and progression [ 83 , 84 ]. Melanin became an extensively exploited biomolecule as potential target in TCT, enabling a selective tumor treatment with therapeutics possessing affinity for the pigment [ 85 ].…”

Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening

“…HER2 is a transmembrane ligand-activated tyrosine kinase that controls cell proliferation, survival, differentiation and adhesion in response to neuregulin (and other ligands) binding. As a result of DNA mutations, HER2 can become overexpressed or continuously activated without the ligand, thereby causing cells over-proliferation [ 151 ]. Similar to doxorubicin, cardiotoxicity constitutes a significant side effect of trastuzumab treatment, thus limiting its use.…”